Veterinary Pathology, Vol 30, Issue 3 213-222, Copyright © 1993 by American College of Veterinary Pathologists

ARTICLES

Production of a monoclonal antibody against canine GMP-140 (P-selectin) and studies of its vascular distribution in canine tissues

M. Dore, H. K. Hawkins, M. L. Entman and C. W. Smith
Speros P. Martel Laboratory of Leukocyte Biology, Department of Pediatrics, Baylor College of Medicine, Houston, TX.

Rapid upregulation of the adhesion molecule GMP-140 (P-selectin) on endothelial cells is believed to play an important role in the initial binding of leukocytes to endothelium, a very early step in the inflammatory response. Activated platelets that are involved in the coagulation system and in inflammatory processes also express GMP-140 on their surfaces. The objectives of the present study were to develop a monoclonal antibody against this adhesion molecule in the dog and to use this antibody to study platelet-neutrophil interactions in whole blood and to characterize the in vivo localization of GMP-140 in canine tissues. Five Balb/c mice were immunized with thrombin-stimulated dog platelets, and clones were screened using an enzyme-linked immunosorbent assay. The clone MD3 (IgG1) showed preferential binding to activated as compared with resting platelets. Flow cytometric analysis using MD3 revealed that 27% of circulating neutrophils in unstimulated blood had platelets bound to their surfaces; stimulation with platelet activating factor increased this percentage to 85%. Immunoblot analysis of solubilized dog platelets resolved by sodium dodecyl sulfate polyacrylamide gel electrophoresis indicated that the antibody MD3 recognized an approximately 140-kd protein. Immunohistochemical study of normal dog tissues with MD3 revealed that the antigen was present in endothelial cells of arteries, capillaries, and veins, depending on the specific tissue examined. Blood vessels staining positively with MD3 were most abundant in the digestive system (liver, stomach, small and large intestines), moderate in the lungs, kidneys, spleen, lymph nodes, and endocrine glands, and minimal in the brain, myocardium, skeletal system, and skin. Based on its presence on stimulated but not resting platelets, its molecular weight, and its vascular distribution, the antigen recognized by MD3 appears to be the selectin GMP-140 of the dog. This study documents that the cellular and tissue distribution of GMP-140 in dogs is very similar to that in human beings.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. Lajoie, J. Sirois, and M. Dore Induction of Cyclo-oxygenase-2 Expression in Naturally Occurring Gastric Ulcers J. Histochem. Cytochem., July 1, 2002; 50(7): 923 - 934. [Abstract] [Full Text] [PDF]

				E. M. P. de Almeida, C. Piche, J. Sirois, and M. Dore Expression of Cyclo-oxygenase-2 in Naturally Occurring Squamous Cell Carcinomas in Dogs J. Histochem. Cytochem., July 1, 2001; 49(7): 867 - 876. [Abstract] [Full Text] [PDF]

				C. Tremblay, M. Paradis, and M. Dore Expression of E- and P-selectin in Tumor Necrosis Factor-induced Dermatitis in Dogs Vet. Pathol., May 1, 2001; 38(3): 261 - 268. [Abstract] [Full Text] [PDF]

				R. J. Gumina, J. Auchampach, R. Wang, E. Buerger, C. Eickmeier, J. Moore, J. Daemmgen, and G. J. Gross Na+/H+ exchange inhibition-induced cardioprotection in dogs: effects on neutrophils versus cardiomyocytes Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1563 - H1570. [Abstract] [Full Text] [PDF]

				D. J. Weiss, M. L. Mirsky, O. A. Evanson, J. Fagliari, D. Mcclenahan, and B. Mccullough Platelet Kinetics in Dogs Treated with a Glycoprotein IIb/IIIa Peptide Antagonist Toxicol Pathol, March 1, 2000; 28(2): 310 - 316. [Abstract] [PDF]

				C. Tremblay, M. Dore, P. N. Bochsler, and J. Sirois Induction of Prostaglandin G/H Synthase-2 in a Canine Model of Spontaneous Prostatic Adenocarcinoma J Natl Cancer Inst, August 18, 1999; 91(16): 1398 - 1403. [Abstract] [Full Text] [PDF]

				M. Arai, Y. Masui, P. Goldschmidt-Clermont, A. DiPaula, C. Siu, T. Kondo, and L. C. Becker P-selectin inhibition prevents early neutrophil activation but provides only modest protection against myocardial injury in dogs with ischemia and forty-eight hours reperfusion J. Am. Coll. Cardiol., July 1, 1999; 34(1): 280 - 288. [Abstract] [Full Text] [PDF]

				M. Dore, L. C. Cote, A. Mitchell, and J. Sirois Expression of Prostaglandin G/H Synthase Type 1, but not Type 2, in Human Ovarian Adenocarcinomas J. Histochem. Cytochem., January 1, 1998; 46(1): 77 - 84. [Abstract] [Full Text]